Explore the next frontier of cancer care with radioligand therapy (RLT)
RLT is changing the paradigm in the treatment of cancer, offering a forward leap in treating certain types of complex cancers1,2
More than 200 types of cancer continue to claim millions of lives each year—in the United States alone, over 2 million new cases of cancer are projected this year.3,4
Explore how RLTs are the turning point in cancer care
References: 1. Data on file. S&G RLT landscape analysis. Novartis Pharmaceuticals Corp; 2024. 2. Palihati M, Das JP, Yeh R, Capaccione K. Emerging PET imaging agents and targeted radioligand therapy: a review of clinical applications and trials. Tomography. 2025;11:83. doi:10.3390/tomography11080083 3. Siegel RL, Kratzer TB, Wagle NS, Sung H, Jemal A. Cancer statistics, 2026. CA Cancer J Clin. 2026;e70043. doi: 10.3322/caac.70043 4. Von Schulze A, Deng F. A review on exosome-based cancer therapy. J Cancer Metastasis Treat. 2020;6:42. doi:10.20517/2394-4722.2020.79